This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Amgen has acquired ChemoCentryx in a deal that includes lead molecule avacopan (Tavneos), a first-in-class orally bioavailable small molecule complement…
Article
4 months ago ●
5 mins read
Context. Sebetralstat (KalVista Pharmaceuticals) is an oral, on-demand plasma kallikrein (PKa) inhibitor intended for hereditary angioedema (HAE). As an on-demand…
molecule
2 months ago ●
5 mins read
You’ve read about the top 10 molecules with publications from July, but what about the ones we found interesting that…
Article
5 months ago ●
8 mins read
Context. GDC-2394 (Genentech) is an oral NLRP3 inflammasome inhibitor. The NLRP3 inflammasome is the best studied and most characterized inflammasome,…
molecule
2 months ago ●
5 mins read
This article is Part VI of a review series covering all the initial public offerings for the biotech and pharmaceutical…
Article
5 months ago ●
7 mins read
Context. “Compound 5g” (Incyte) is a selective cyclin-dependent kinase 2 (CDK2) inhibitor. Although CDK2 is a highly pursued cancer drug…
molecule
2 months ago ●
4 mins read
Load More
